BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18297112)

  • 1. Plk1 depletion in nontransformed diploid cells activates the DNA-damage checkpoint.
    Lei M; Erikson RL
    Oncogene; 2008 Jun; 27(28):3935-43. PubMed ID: 18297112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal cells, but not cancer cells, survive severe Plk1 depletion.
    Liu X; Lei M; Erikson RL
    Mol Cell Biol; 2006 Mar; 26(6):2093-108. PubMed ID: 16507989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals.
    Guan R; Tapang P; Leverson JD; Albert D; Giranda VL; Luo Y
    Cancer Res; 2005 Apr; 65(7):2698-704. PubMed ID: 15805268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.
    Shtivelman E
    Mol Cancer Res; 2003 Nov; 1(13):959-69. PubMed ID: 14638868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of Survivin expression.
    He Z; Wu J; Dang H; Lin H; Zheng H; Zhong D
    Cancer Lett; 2011 Apr; 303(2):92-8. PubMed ID: 21330050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
    Reagan-Shaw S; Ahmad N
    FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting in and out of mitosis with Polo-like kinase-1.
    van Vugt MA; Medema RH
    Oncogene; 2005 Apr; 24(17):2844-59. PubMed ID: 15838519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y; Yang Z; Li Q; Song F
    Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
    Zhou Q; Bai M; Su Y
    Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
    Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
    Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
    Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
    Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polo-like kinase 1 may regulate G2/M transition of mouse fertilized eggs by means of inhibiting the phosphorylation of Tyr 15 of Cdc2.
    Zhang Z; Su WH; Feng C; Yu DH; Cui C; Xu XY; Yu BZ
    Mol Reprod Dev; 2007 Oct; 74(10):1247-54. PubMed ID: 17342725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitosis arrest caused by inhibition of PLK1 expression in gastric cancer MKN45 cells].
    Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):164-8. PubMed ID: 16875597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antisense RNA targeting polo-like kinase 1 on cell cycle and proliferation in A549 cells.
    Zhou Q; Bai M; Su Y
    Chin Med J (Engl); 2004 Nov; 117(11):1642-9. PubMed ID: 15569479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo].
    Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):40-4. PubMed ID: 16620646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
    Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
    Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plk1 is negatively regulated by RNF8.
    Yoshioka T; Kimura M; Saio M; Era S; Okano Y
    Biochem Biophys Res Commun; 2011 Jun; 410(1):57-61. PubMed ID: 21635870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Plk1 induces mitotic infidelity and embryonic growth defects in developing zebrafish embryos.
    Jeong K; Jeong JY; Lee HO; Choi E; Lee H
    Dev Biol; 2010 Sep; 345(1):34-48. PubMed ID: 20553902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
    Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT
    Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression.
    Lee M; Daniels MJ; Venkitaraman AR
    Oncogene; 2004 Jan; 23(4):865-72. PubMed ID: 14647413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.